Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
45,703
Total Claims
$9.2M
Drug Cost
629
Beneficiaries
$15K
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+934%
Cost per patient vs peers
$15K vs $1,411 avg
+178%
Brand preference vs peers
29.6% vs 10.6% avg
🔎 Data Overview
Cost per patient is 934% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Brand vs Generic
Brand: 13,364 claims · $7.2M
Generic: 31,856 claims · $1.9M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Cyclosporine | 1,905 | $1.4M |
| Icosapent Ethyl | 2,905 | $1.2M |
| Diclofenac Epolamine | 1,073 | $706K |
| Lipase/Protease/Amylase | 377 | $669K |
| Sitagliptin Phosphate | 830 | $515K |
| Omeprazole/Sodium Bicarbonate | 432 | $491K |
| Tenofovir Alafenamide | 181 | $281K |
| Semaglutide | 264 | $268K |
| Linaclotide | 468 | $264K |
| Dexlansoprazole | 936 | $233K |
| Halobetasol Propionate | 1,652 | $209K |
| Mometasone Furoate | 1,505 | $187K |
| Esomeprazole Magnesium | 996 | $168K |
| Fluticasone Propion/Salmeterol | 331 | $145K |
| Naproxen/Esomeprazole Mag | 142 | $132K |
Prescribing Profile
Patient Profile
72
Avg Age
50%
Female
0.90
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data